Manipal Health Enterprises Ltd, one of India’s leading integrated healthcare providers operating through a pan‑India network of multi‑specialty hospitals, clinics, and diagnostic centres, made a strong debut on the NSE and BSE on 05 Aug 2026, listing at ₹652 against an issue price of ₹590. This debut translated into a listing‑day gain of +10.5%, a performance that underscores robust investor enthusiasm on listing day. The company did not witness any bulk deals on its debut, indicating a clean and orderly opening.
Against the backdrop of its extensive healthcare footprint—spanning primary to quaternary care with strengths in specialties such as oncology, cardiology, neurosciences, orthopaedics, gastro sciences, and renal sciences—this listing performance not only reflects market confidence in the company’s clinical positioning but also signals strong retail and institutional interest at launch.
| Issue Price | ₹590 |
| Listing Price | ₹652 |
| Closing Price | – |
| Listing Day Gain | +10.5% |
No bulk deals were reported for Manipal Health Enterprises Ltd on listing day.
See the full profile on the Manipal Health Enterprises Ltd IPO page.
Listing and closing price figures are sourced from official exchange data feeds.